OmniStar Financial Group
WST icon

OmniStar Financial Group’s West Pharmaceutical WST Stock Holding History

OmniStar Financial Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-629
Closed -$226K – 150
2026
Q2 		$226K Buy
+629
New +$192K 0.1% 106
2020
Q2 		– Sell
-100
Closed -$15K – 309
2020
Q1 		$15K Buy
+100
New +$15.4K 0.01% 200

Other funds holding WST

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

OmniStar Financial Group's WST Position: Q3 2026 in Review

OmniStar Financial Group sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 629 shares — an estimated $226K sold.

OmniStar Financial Group first reported a position in WST in Q1 2020 and held it in 2 quarters. The position peaked at $226K in Q2 2026. 470 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • OmniStar Financial Group reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • OmniStar Financial Group sold 629 West Pharmaceutical shares in Q3 2026, an estimated $226K.
  • OmniStar Financial Group first reported a position in West Pharmaceutical in Q1 2020 and held it in 2 quarters.
  • OmniStar Financial Group's West Pharmaceutical position peaked at $226K in Q2 2026.
  • 470 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on OmniStar Financial Group's 13F filing for Q3 2026, filed 26 Oct 2026.